Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (631-640 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|December 18, 2024
Oral acute graft-versus-host diseaseFarzad Teymouri, Gale Sebastian, Hakan Gem, et al.
Ejhaem|December 18, 2024
<i>RUNX1::CBFA2T2</i> rearranged acute myeloid leukemia transformed from <i>JAK2</i> V617F mutated primary myelofibrosisLina Han, Prasad Koduru, Miguel Cantu, et al.
Ejhaem|February 13, 2025
Acute myeloid leukemia with RAM immunophenotype: A report of three patients and comprehensive literature reviewXenia Parisi, Anindita Ghosh, L Jeffrey Medeiros
Ejhaem|February 10, 2025
Intramedullary erythrophagocytosis in myelodysplastic syndrome with heterozygous U2AF1 Q157R variantKritika Krishnamurthy, Aditi Shastri, Yanhua Wang
Ejhaem|February 7, 2025
Elimination of residual adult T-cell leukaemia clones by Tax-targeted dendritic cell vaccineTadafumi Iino, Atsuhiko Hasegawa, Takaji Matsutani, et al.
Ejhaem|November 29, 2023
Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with <i>TP53</i> disruptionsShyam A Patel, Jan Cerny, William K Gerber, et al.
Ejhaem|November 29, 2023
The role of tocilizumab in the treatment of post-transfusion hyperhaemolysisNaeem Desai, Jayne Peters, Elizabeth Davies, et al.
Ejhaem|November 29, 2023
A comparison of the prognostic performance of the Lugano 2014 and RECIL 2017 response criteria in patients with NHL from the phase III GOYA and GALLIUM trialsLale Kostakoglu, Maurizio Martelli, Laurie H Sehn, et al.
Ejhaem|November 29, 2023
Use of glucarpidase (carboxypeptidase-G2) in pediatric cancer patients: 11-year experience of a tertiary centerRocío Vila, Alba Rubio-San-Simón, Pablo Zubiaur, et al.
Ejhaem|November 29, 2023
PET-based radiomics signature can predict durable responses to CAR T-cell therapy in patients with large B-cell lymphomaMarta Ligero, Marc Simó, Cecilia Carpio, et al.
Pageof 93

Showing results (631-640 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|December 18, 2024
Oral acute graft-versus-host diseaseFarzad Teymouri, Gale Sebastian, Hakan Gem, et al.
Ejhaem|December 18, 2024
<i>RUNX1::CBFA2T2</i> rearranged acute myeloid leukemia transformed from <i>JAK2</i> V617F mutated primary myelofibrosisLina Han, Prasad Koduru, Miguel Cantu, et al.
Ejhaem|February 13, 2025
Acute myeloid leukemia with RAM immunophenotype: A report of three patients and comprehensive literature reviewXenia Parisi, Anindita Ghosh, L Jeffrey Medeiros
Ejhaem|February 10, 2025
Intramedullary erythrophagocytosis in myelodysplastic syndrome with heterozygous U2AF1 Q157R variantKritika Krishnamurthy, Aditi Shastri, Yanhua Wang
Ejhaem|February 7, 2025
Elimination of residual adult T-cell leukaemia clones by Tax-targeted dendritic cell vaccineTadafumi Iino, Atsuhiko Hasegawa, Takaji Matsutani, et al.
Ejhaem|November 29, 2023
Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with <i>TP53</i> disruptionsShyam A Patel, Jan Cerny, William K Gerber, et al.
Ejhaem|November 29, 2023
The role of tocilizumab in the treatment of post-transfusion hyperhaemolysisNaeem Desai, Jayne Peters, Elizabeth Davies, et al.
Ejhaem|November 29, 2023
A comparison of the prognostic performance of the Lugano 2014 and RECIL 2017 response criteria in patients with NHL from the phase III GOYA and GALLIUM trialsLale Kostakoglu, Maurizio Martelli, Laurie H Sehn, et al.
Ejhaem|November 29, 2023
Use of glucarpidase (carboxypeptidase-G2) in pediatric cancer patients: 11-year experience of a tertiary centerRocío Vila, Alba Rubio-San-Simón, Pablo Zubiaur, et al.
Ejhaem|November 29, 2023
PET-based radiomics signature can predict durable responses to CAR T-cell therapy in patients with large B-cell lymphomaMarta Ligero, Marc Simó, Cecilia Carpio, et al.
Pageof 93